MSLE — Satellos Bioscience
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore musc...
Satellos Bioscience Inc is a Canadian biotechnology and drug development company. The company is developing novel therapeutics that stimulate or restore muscle regeneration in severe disorders. The company's program is focused on developing an oral therapeutic drug for Duchenne muscular dystrophy that serves to correct this dysregulation, which Satellos has identified as a root cause of the progressive nature of this disease.
- Industry
- Biotechnology
- Sector
- Healthcare
- Exchange
- NASD
- First trade date
- 2021-08-18
The interactive platform loads with JavaScript. Research tools are for informational purposes.